TAE Technologies

TAE Technologies is developing an aneutronic fusion reactor. The reactor combines field-reversed configuration with plasma merging via particle beams to achieve fusion. TAE nicknames their machines “Norman” based on their late co-founder Norman Rostoker. Their next machine, Copernicus, is planned to produce net energy during the first part of the 2020s.

TAE is also using their beam technology to fight cancer.

TAE has invested over $100 million USD into their research and reactors. TAE was funded in part by Paul Allen, co-founder of Microsoft, the Venrock firm and Goldman Sachs.